This stock biotech stock came across my radar while doing my weekend review of stocks to watch. Today the stock showed to have great potential as a swing-trade candidate. Ovid Pharmaceuticals (Nasdaq: … [Read more...] about Quick Draw Swing Move
Swing Trades
Pdufa Watch
Nabriva's Hype It has been decades since the US has seen a new novel treatment in the antibiotics arena, creating positive sentiment surrounding the approval of Nabriva's Contepo (fosfomycin). … [Read more...] about Pdufa Watch
Biotech Bull Move
Recently MS covered a play on the leveraged ETF known as LABD. After pulling 30%+ gains, the team has exited and begun eyeing a new opportunity in the same space. M&A optimism and high … [Read more...] about Biotech Bull Move
Why I’m Bullish On Brexit: Part deux
As the Market's overheating, (Nasdaq: LABD) the S&P Biotech Bear 3x hits all-time lows, and Brexit fears loom. LABD gives a nice potential entry for biotech traders looking for protection the next … [Read more...] about Why I’m Bullish On Brexit: Part deux
MS Swing Move #Focused
Nasdaq: EYPT) Eyepoint Pharmaceuticals #focus by follow_the_money on TradingView.com This past week Eyepoint Pharmaceuticals filed form 4's three days in a row. Interestingly, this week Eyepoint … [Read more...] about MS Swing Move #Focused
ADMA Presents Potential Entry For Investors On The Sideline
Today Adma Biologics (Nasdaq: ADMA) sold off ~10% closing at $3.50. Most of us already in Adma were not phased. Personally, I saw this as a healthy pullback. Since February 1st ADMA has gained 25% … [Read more...] about ADMA Presents Potential Entry For Investors On The Sideline
Buying The Panic
For this move, we are buying the panic. Insys Therapeutics (Nasdaq: INSY) has dropped significantly in the past few weeks. The downtrend started following INSY's fourth-quarter 2018 earnings … [Read more...] about Buying The Panic
(Nasdaq: GALT) Galectin Therapeutics, Reversal?
According to Elliot wave theory and Fibonacci ratio, GALT is showing bullish signs of reversal. GALT ran up from $3.19 to $6.06. It has since pulled back to ~$4.19 (also, .786 retracement) #KEY … [Read more...] about (Nasdaq: GALT) Galectin Therapeutics, Reversal?
More Near-Term Downside For KPTI
KPTI's data does not adequately demonstrate a treatment benefit from Oral Selinexor plus low-dose dexamethasone in Penta-Relapsed/Refractory Multiple Myeloma (RRMM).Serious adverse events during … [Read more...] about More Near-Term Downside For KPTI
Technically Swinging CNAT
Swing Thesis This swing-trade for Conatus Pharmaceuticals, (Nasdaq: CNAT) is based on Technical Analysis (which aligns with some key dates) and a fundamental component. With regards to technical … [Read more...] about Technically Swinging CNAT
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish